Today: 19 May 2026
Browse Category

NYSE:DHR 21 October 2025 - 15 February 2026

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares edged up 0.1% to $219.83 Friday after steep losses earlier in the week. The company reported Q4 revenue of $6.84 billion and adjusted EPS of $2.23, with 2026 earnings guidance in line with analyst forecasts. Investors remain cautious amid weak academic research funding and recent stock swings. Vanguard disclosed an 8.63% stake in Danaher as of Dec. 31.
30 January 2026
·····
Danaher stock slides again after outlook: what DHR investors are watching next

Danaher stock slides again after outlook: what DHR investors are watching next

Danaher shares fell 2.2% to $219.49 Thursday after its 2026 profit outlook matched analyst estimates. Fourth-quarter revenue rose 4.5% to $6.8 billion, with adjusted earnings at $2.23 per share. CEO Rainer Blair said China diagnostics revenue declined only slightly in Q4, improving from previous quarters. Investors remain cautious as sector peers warn of continued weakness in academic research spending.
29 January 2026
··
Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Danaher shares fell 4.8% to $224.54 after its 2026 profit outlook matched analyst expectations. The company beat fourth-quarter profit and revenue estimates, posting $6.8 billion in revenue and $2.23 per share in adjusted earnings. Trading volume more than doubled its 50-day average. Investors focused on the pace of recovery and upcoming results from rival Thermo Fisher.
29 January 2026
··
Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher shares closed down 0.42% at $235.60 Wednesday, then edged up 0.16% after hours. CEO Rainer Blair will present at the J.P. Morgan Healthcare Conference Jan. 13, with Q4 earnings set for Jan. 28. Evercore ISI and TD Cowen raised price targets to $250 and $270, respectively. The stock traded between $233.26 and $238.00, with 2.7 million shares changing hands.
8 January 2026
··
Danaher (DHR) Stock After Hours on Dec. 24, 2025: What Happened After the Early Close — and What to Know Before the Next Market Open

Danaher (DHR) Stock After Hours on Dec. 24, 2025: What Happened After the Early Close — and What to Know Before the Next Market Open

Danaher closed at $231.47, up 0.28%, in a light, holiday-shortened session on Dec. 24, with after-hours trading slipping to $231.39. Trading volume was about 785,700 shares. A shareholder-rights law firm announced an investigation into Danaher’s officers and directors. No new corporate press releases were issued by the company.
25 December 2025
·
Danaher Stock (DHR) News Today: BofA Lifts Price Target to $265, Wells Fargo to $240 as 2026 Normalization Comes Into Focus

Danaher Stock (DHR) News Today: BofA Lifts Price Target to $265, Wells Fargo to $240 as 2026 Normalization Comes Into Focus

Danaher shares traded near $227 Monday after Bank of America raised its price target to $265 and Wells Fargo lifted its target to $240. Both cited expectations for demand normalization in 2026. Bank of America kept a Buy rating, while Wells Fargo maintained Equal-Weight. Analysts highlighted Danaher as a key indicator for life sciences and diagnostics sector trends.
15 December 2025
·
Danaher Stock After Hours (Dec. 11, 2025): DHR Holds a Breakout Level—What to Watch Before the Market Opens Friday

Danaher Stock After Hours (Dec. 11, 2025): DHR Holds a Breakout Level—What to Watch Before the Market Opens Friday

Danaher closed Thursday at $232.37, up 0.85%, and edged to $232.99 in after-hours trading. The stock finished just above a key technical buy point near $232.34. Analyst targets remain in the mid-$250s after bullish commentary earlier in the week. No major company news or macro events are expected before Friday’s open.
12 December 2025
··
Danaher (DHR) Stock on December 4, 2025: Analyst Upgrades, Q3 Beat and Governance Probes Shape the 2026 Outlook

Danaher (DHR) Stock on December 4, 2025: Analyst Upgrades, Q3 Beat and Governance Probes Shape the 2026 Outlook

Danaher shares traded at $227–$229 Thursday, rebounding over 30% from April’s low but still 11–12% below the 52-week high. The company faces board governance probes as Morgan Stanley upgrades the stock and new institutional buyers emerge. Danaher forecasts mid-single-digit revenue growth and margin expansion for 2026. Q3 2025 saw 3% core revenue growth and $2 billion in share buybacks.
4 December 2025
··
Danaher (DHR) Stock on December 1, 2025: Q3 Beat, Legal Probes and Fresh Price Targets – Is the Premium Still Worth Paying?

Danaher (DHR) Stock on December 1, 2025: Q3 Beat, Legal Probes and Fresh Price Targets – Is the Premium Still Worth Paying?

Danaher traded near $225 per share on December 1, 2025, down about 1%–2% year-to-date and roughly 12% below its 52-week high. Market cap stands at $159–160 billion. Halper Sadeh LLC launched a shareholder-rights investigation into Danaher officers and directors on November 28, following similar probes by Rosen Law Firm in October. No lawsuits or regulatory actions have been filed.
1 December 2025
··
Danaher (DHR) Stock: Price, News and Analyst Forecast Before the December 1, 2025 Market Open

Danaher (DHR) Stock: Price, News and Analyst Forecast Before the December 1, 2025 Market Open

Danaher closed November 28 at $226.78, down 0.7%, with shares trading in a tight range and volume near 1.46 million. A shareholder-rights investigation was announced November 28 by Halper Sadeh LLC, targeting potential breaches by Danaher officers and directors. The company’s market cap stands near $160 billion, with a trailing P/E around 46–47x and a quarterly dividend of $0.32.
1 December 2025
·
Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher (DHR) Stock Surges After Q3 Earnings – Analysts See Further Upside

Danaher shares jumped 7% on Oct. 21 after Q3 adjusted EPS of $1.89 beat estimates and revenue reached $6.05 billion, up 4.5% year-over-year. The company kept its 2025 EPS guidance at $7.70–$7.80 and announced a $2 billion share buyback. Shares traded near $208, up 8% in a month but still down 20% from a year ago. Most analysts rate the stock a buy, with an average target of $245.
21 October 2025
···
1 2

Stock Market Today

  • US Stocks Retreat From Records Amid Tech Sell-Off and Nvidia Earnings Anticipation
    May 19, 2026, 11:09 AM EDT. U.S. stocks declined further from record highs on Tuesday, with the S&P 500 down 0.5% and the Dow Jones Industrial Average falling 0.8%, pressured by slowing technology shares. The Nasdaq dropped 0.6% ahead of Nvidia's quarterly earnings report, which investors see as a key indicator for the tech sector's direction. Nvidia shares dipped 0.7%. Global markets showed mixed results: South Korea's Kospi fell 3.3%, while Germany's DAX rose 1%. Oil prices eased slightly to $111.39 a barrel despite geopolitical tensions related to the Iran war impacting global oil supply routes. Treasury yields increased, with the 10-year rising to 4.66%. Investors brace for further market volatility as tech enthusiasm cools and macroeconomic uncertainties persist.

Latest articles

Nebius Drops After Google, Blackstone Step Up 2026 AI Cloud Bet

Nebius Drops After Google, Blackstone Step Up 2026 AI Cloud Bet

19 May 2026
Nebius Group N.V. shares dropped 7.5% to $184.84 in Nasdaq morning trading after Google and Blackstone announced a $5 billion U.S. AI cloud venture and D.A. Davidson downgraded the stock. CoreWeave, a peer, also fell 7.8%. Nebius reported Q1 revenue of $399 million, up 684% year-over-year, and raised its 2026 capital expenditure forecast to as much as $25 billion.
Generation Income Properties Up 46% After Heavy Volume

Generation Income Properties Up 46% After Heavy Volume

19 May 2026
Generation Income Properties shares surged 45.5% to $0.3549 in early Nasdaq trading Tuesday, with volume above 105 million shares. The spike followed insider-ownership filings after a board shakeup, not new earnings or property sales. The company reported a $2.13 million quarterly loss and warned of “substantial doubt” about its ability to continue as a going concern. Nasdaq has given it until August 4 to meet equity requirements.
Snowflake Shares Jump Ahead of Results as Wall Street Bets on AI Demand

Snowflake Shares Jump Ahead of Results as Wall Street Bets on AI Demand

19 May 2026
Snowflake shares rose 6.3% to $174.62 in morning trading Tuesday, outperforming major U.S. index funds. BofA Securities raised its price target to $205, citing strong demand for Snowflake’s AI tools. The company reports fiscal first-quarter results after the U.S. market close on May 27. Trading volume reached 3.6 million shares, with a market value near $59.4 billion.

Popular

Ondas Shares Drop Following $199 Million AI Defense Deal, Traders Eye Next Steps

Ondas Shares Drop Following $199 Million AI Defense Deal, Traders Eye Next Steps

18 May 2026
Ondas Inc. shares dropped about 10% to $9.555 in midday Nasdaq trading Monday after announcing a $199 million all-stock acquisition of Israeli defense software firm Omnisys and filing for potential resale of over 2.2 million shares tied to a previous deal. Trading volume topped 48 million shares. The Omnisys deal is expected to close in Q2, pending approvals and retention of key staff.
Go toTop